Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Factor VIII gene variants and inhibitor risk in African American hemophilia A patients

Devi Gunasekera, Ruth A. Ettinger, Shelley Nakaya Fletcher, Eddie A. James, Maochang Liu, John C. Barrett, Janice Withycombe, Dana C. Matthews, Melinda S. Epstein, Richard J. Hughes, Kathleen P. Pratt

Blood (2015) 126 (7): 895–904.

https://doi.org/10.1182/blood-2014-09-599365

Published: 2015

Includes: Supplemental data

Journal Articles

Factor VIII Gene Variants and Inhibitor Risk in African American Hemophilia a Patients

Devi Gunasekera, MD, Ruth A. Ettinger, PhD, Shelley Nakaya Fletcher, B.S., Eddie A. James, PhD, Maochang Liu, PhD, John C. Barrett, MD, Janice Withycombe, PhD, R.N., M.N., C.C.R.P., Dana C. Matthews, MD, Melinda S. Epstein, PhD, Richard J. Hughes, PhD, Kathleen P. Pratt, PhD

Blood (2014) 124 (21): 235.

https://doi.org/10.1182/blood.V124.21.235.235

Published: 2014

Journal Articles

Factor VIII Mutation and Desmopressin-Responsiveness in 63 Patients with Mild Hemophilia A

Danielle Nance, MD, Shelley Nakaya Fletcher, Doug C Bolgiano, MS, Arthur R. Thompson, MD, PhD, Neil C. Josephson, MD, Barbara A. Konkle, M.D.

Blood (2011) 118 (21): 1203.

https://doi.org/10.1182/blood.V118.21.1203.1203

Published: 2011

Journal Articles

Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent.

Tom E. Howard, MD, PhD, Kevin R. Viel, BS, Karl M. Fernstrom, BS, Seema Deshpande, PhD, Afshin Ameri, MD, M. Showkat Ali, PhD, Cynthia Channell, BS, Rathi V. Iyer, MD, Raymond G. Watts, MD, Charles Lutcher, MD, Shelley Nakaya, BS, Carol K. Kasper, MD, Arthur R. Thompson, MD, PhD, Thomas C. Abshire, MD, Laura Almasy, PhD

Blood (2006) 108 (11): 765.

https://doi.org/10.1182/blood.V108.11.765.765

Published: 2006

Journal Articles

Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure

Miao-Liang Liu, Betty W. Shen, Shelley Nakaya, Kathleen P. Pratt, Kazuo Fujikawa, Earl W. Davie, Barry L. Stoddard, Arthur R. Thompson

Blood (2000) 96 (3): 979–987.

https://doi.org/10.1182/blood.V96.3.979

Published: 2000

NARROW

Factor VIII gene variants and inhibitor risk in African American hemophilia A patients

Factor VIII Gene Variants and Inhibitor Risk in African American Hemophilia a Patients

Factor VIII Mutation and Desmopressin-Responsiveness in 63 Patients with Mild Hemophilia A

Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent.

Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure

Email alerts

ASH Publications

American Society of Hematology

Factor VIII gene variants and inhibitor risk in African American hemophilia A patients

Factor VIII Gene Variants and Inhibitor Risk in African American Hemophilia a Patients

Factor VIII Mutation and Desmopressin-Responsiveness in 63 Patients with Mild Hemophilia A

Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent.

Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only